Clinical Study of XP-005 Personalized Vaccine Alone or in Combination With Toripalimab to Prevent the Relapse of Acute Myeloid Leukemia After Consolidation Therapy
Latest Information Update: 28 May 2025
At a glance
- Drugs XP 005 (Primary) ; Toripalimab
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
Most Recent Events
- 28 May 2025 New trial record